What is your preferred approach to PMRT with inflammatory breast cancer with adverse risk features?

Topics: Breast Cancer • Radiation Oncology

What is your preferred approach to PMRT with inflammatory breast cancer with adverse risk features (i.e. age <45, close/positive margins or poor response to neoadjuvant therapy)?

Answer from: Radiation Oncologist at Community Practice

Our approach is same of 50 Gy in 25 fractions to CW and Regional node with higher boost dose of 10-16 Gy

Comments

Radiation Oncologist at Cleveland Clinic
Agreed, I use standard fractionation with a boost...

Radiation Oncologist at Northwestern University
I concur with others and emphasize the use of dail...

Answer from: Radiation Oncologist at Academic Institution

Inflammatory breast cancer is most commonly triple negative or HER2 amplified disease. Patients with significant residual disease after preoperative chemotherapy have extremely high rates of relapse. Participation on SWOG1706 (NCT03598257, @Reshma Jagsi PI), a phase II randomized trial of ...

Comments

Radiation Oncologist at University of Texas MD Anderson Cancer Center
We offer BID radiation to the chest wall and nodes...

Radiation Oncologist at Northwestern University
I'd just like to put in a plug for listening to th...

Related Questions